Simmunome AI
Simmunome Inc. is a SaaS company providing a no-code, high-fidelity AI-driven platform for disease simulations to accelerate drug development. Their platform includes tools like BioTarget™ Scoring Tool for predicting target efficacy, Omic Signatures™ for identifying predictive biomarkers, and a Data Exploration Tool for versatile data visualization. They offer a library of disease models across oncology, neurodegenerative diseases, and regenerative medicine, enabling clients to make informed decisions and reduce R&D costs. Their hybrid approach combines mechanistic modeling and machine learning to deliver traceable, reliable predictions, supporting translational biology and clinical trial success. Simmunome collaborates with pharmaceutical companies and research institutions, emphasizing secured access, custom data integration, and explainability in AI models to improve patient outcomes and drug development efficiency.
Simmunome AI
Simmunome Inc. is a SaaS company providing a no-code, high-fidelity AI-driven platform for disease simulations to accelerate drug development. Their platform includes tools like BioTarget™ Scoring Tool for predicting target efficacy, Omic Signatures™ for identifying predictive biomarkers, and a Data Exploration Tool for versatile data visualization. They offer a library of disease models across oncology, neurodegenerative diseases, and regenerative medicine, enabling clients to make informed decisions and reduce R&D costs. Their hybrid approach combines mechanistic modeling and machine learning to deliver traceable, reliable predictions, supporting translational biology and clinical trial success. Simmunome collaborates with pharmaceutical companies and research institutions, emphasizing secured access, custom data integration, and explainability in AI models to improve patient outcomes and drug development efficiency.